Pharmaceutical

STAT+: FDA’s Woodcock reflects on more than 30 years at...

It’s the end of an era for the FDA’s longtime drug chief, Janet Woodcock. But sh...

STAT+: Sophisticated phishing and deepfakes: How genera...

Security experts caution that health care systems are particularly at risk as ha...

Can the government ask social media sites to take down ...

SCOTUS will consider whether the government’s requests for sites to moderate Cov...

Supreme Court slates abortion pill case for March

The Supreme Court will hear arguments about access to the abortion medication mi...

Opinion: I’m an anesthesiologist. Kenneth Smith’s execu...

Alabama says that Kenneth Smith's execution was "textbook." What textbook are th...

Scientists document first-ever transmitted Alzheimer’s ...

Scientists document the first-ever transmitted Alzheimer’s cases, tied to a no-l...

STAT+: European regulators tout their accomplishments a...

European antitrust regulators want you to know that fighting crime in the pharma...

23andMe breach targeted Chinese, Jewish populations

A new lawsuit accuses 23andMe of failing to protect the privacy of customers who...

Moderna leads the development of mRNA vaccines in infec...

The rapid sequencing of the SARS-CoV-2 and the subsequent development of mRNA va...

Pfizer and Astellas seek updated EMA approval for Padce...

Results from a Phase III trial indicated that adding MSD’s blockbuster drug boos...

Merck is on the lookout for more opportunities within i...

At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to c...

Cell and gene therapies – top pharmaceutical industry t...

The full potential of cell and gene therapies (CGTs) has not yet been discovered...

Cristália signs licensing deal for Formosa’s APP13007

Cristália has signed an agreement to license exclusive rights to market Formosa ...

FDA grants priority review for Daiichi Sankyo-AstraZene...

The US FDA has granted priority review to the sBLA for ENHERTU, a treatment deve...

Celltrion USA seeks FDA approval for CT-P47 biosimilar

Celltrion USA has filed a biologics licence application (BLA) with the US FDA fo...

Bristol Myers Squibb’s Abecma recommended for EU approval

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s ...